Inverse Expression Levels of EphrinA3 and EphrinA5 Contribute to Dopaminergic Differentiation of Human SH-SY5Y Cells

Journal of Molecular Neuroscience

Volumn 59, Issue 4, 2016, Pages 483-492

  Wang, Ting ^a   Chen, Jing ^a   Tang, Chuan Xi ^a   Zhou, Xiao Yan ^a   Gao, Dian Shuai ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Axon guidance; Cellular therapy; EphrinAs; Parkinson s disease

Indexed keywords

DOPAMINE TRANSPORTER; EPHRIN A3; EPHRIN A5; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; MESSENGER RNA; MICRORNA; TYROSINE 3 MONOOXYGENASE;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; DOPAMINERGIC NERVE CELL; DOWN REGULATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; NERVE FIBER GROWTH; NEUROBLASTOMA CELL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; CYTOLOGY; GENETICS; METABOLISM; TUMOR CELL LINE;

CELL DIFFERENTIATION; CELL LINE, TUMOR; DOPAMINERGIC NEURONS; EPHRIN-A3; EPHRIN-A5; HUMANS;

EID: 84969871595     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/s12031-016-0759-y     Document Type: Article

References (56)

1. Aschrafi A, Schwechter AD, Mameza MG, Natera-Naranjo O, Gioio AE, Kaplan BB (2008) MicroRNA-338 regulates local cytochrome c oxidase IV mRNA levels and oxidative phosphorylation in the axons of sympathetic neurons. J Neurosci 28:12581–12590
2. Bartel DP (2009) MicroRNAs target recognition and regulatory functions. Cell 136:215–233
3. Bové J, Prou D, Perier C, Przedborski S (2005) Toxin-induced models of Parkinson’s disease. NeuroRx 2:484–494
4. Brownlee H, Gao PP, Frisén J, Dreyfus C, Zhou R, Black IB (2000) Multiple ephrins regulate hippocampal neurite outgrowth. J Comp Neurol 425:315–322
5. Bu L, Li R, Liu H, et al. (2014) Intrastriatal transplantation of retinal pigment epithelial cells for the treatment of Parkinson disease: in vivo longitudinal molecular imaging with 18F-P3BZA PET/CT. Radiology 272:174–183
6. Bush JO, Soriano P (2012) Eph/ephrin signaling: genetic, phosphoproteomic, and transcriptomic approaches. Semin Cell Dev Biol 23:26–34
7. Cang J, Wang L, Stryker MP, Feldheim DA (2008) Roles of ephrin-as and structured activity in the development of functional maps in the superior colliculus. J Neurosci 28:11015–11023
8. Carmona MA, Murai KK, Wang L, Roberts AJ, Pasquale EB (2009) Glial ephrin-A3 regulates hippocampal dendritic spine morphology and glutamate transport. Proc Natl Acad Sci U S A 106:12524–12529
9. Cheng H-J, Nakamoto M, Bergemann AD, Flanagan JG (1995) Complementary gradients in expression and binding of ELF-1 and Mek4 in development of the topographic retinotectal projection map. Cell 82:371–381
10. Cowan CA, Henkemeyer M (2002) Ephrins in reverse, park and drive. Trends Cell Biol 12:339–346
11. Cutforth T, Moring L, Mendelsohn M, et al. (2003) Axonal ephrin-as and odorant receptors: coordinate determination of the olfactory sensory map. Cell 114:311–322
12. Dajas-Bailador F, Bonev B, Garcez P, Stanley P, Guillemot F, Papalopulu N (2012) microRNA-9 regulates axon extension and branching by targeting Map1b in mouse cortical neurons. Nat Neurosci 15:697–699
13. Davy A, Robbins SM (2000) Ephrin-A5 modulates cell adhesion and morphology in an integrin-dependent manner. EMBO J 19:5396–5405
14. Davy A, Soriano P (2005) Ephrin signaling in vivo: look both ways. Dev Dyn 232:1–10
15. Deumens R, Blokland A, Prickaerts J (2002) Modeling Parkinson’s disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway. Exp Neurol 175:303–317
16. Drescher U, Kremoser C, Handwerker C, Loschinger J, Noda M, Bonhoeffer F (1995) In vitro guidance of retinal ganglion cell axons by RAGS, a 25 kDa tectal protein related to ligands for Eph receptor tyrosine kinases. Cell 82:359–370
17. Dufour A, Seibt J, Passante L, et al. (2003) Area specificity and topography of thalamocortical projections are controlled by ephrin/Eph genes. Neuron 39:453–465
18. Feldheim DA, Kim YI, Bergemann AD, Frisén J, Barbacid M, Flanagan JG (2000) Genetic analysis of ephrin-A2 and ephrin-A5 shows their requirement in multiple aspects of retinocollicular mapping. Neuron 25:563–574
19. Flanagan JG (2006) Neural map specification by gradients. Curr Opin Neurobiol 16:59–66
20. Flanagan JG, Vanderhaeghen P (1998) The ephrins and Eph receptors in neural development. Annu Rev Neurosci 21:309–345
21. Frisén J, Yates PA, McLaughlin T, Friedman GC, O’Leary DD, Barbacid M (1998) Ephrin-A5 (AL-1/RAGS) is essential for proper retinal axon guidance and topographic mapping in the mammalian visual system. Neuron 20:235–243
22. Grealish S, Xie L, Kelly M, Dowd E (2008) Unilateral axonal or terminal injection of 6-hydroxydopamine causes rapid-onset nigrostriatal degeneration and contralateral motor impairments in the rat. Brain Res Bull 77:312–319
23. Grunwald IC, Korte M, Adelmann G, et al. (2004) Hippocampal plasticity requires postsynaptic ephrinBs. Nat Neurosci 7:33–40
24. Hattori M, Osterfield M, Flanagan JG (2000) Regulated cleavage of a contact-mediated axon repellent. Science 289:1360–1365
25. Hengst U, Cox LJ, Macosko EZ, Jaffrey SR (2006) Functional and selective RNA interference in developing axons and growth cones. J Neurosci 26:5727–5732
26. Heuer A, Lelos MJ, Kelly CM, Torres EM, Dunnett SB (2013) Dopamine-rich grafts alleviate deficits in contralateral response space induced by extensive dopamine depletion in rats. Exp Neurol 247:485–495
27. Himanen JP, Rajashankar KR, Lackmann M, Cowan CA, Henkemeyer M, Nikolov DB (2001) Crystal structure of an Eph receptor-ephrin complex. Nature 414:933–938
28. Holmberg J, Frisén J (2002) Ephrins are not only unattractive. Trends Neurosci 25:239–243
29. Holmberg J, Clarke DL, Frisén J (2000) Regulation of repulsion versus adhesion by different splice forms of an Eph receptor. Nature 408:203–206
30. Kiessling F (2014) Science to practice: cellular therapy of Parkinson disease—a new radiotracer to target transplanted dopaminergic cells with PET. Radiology 272:1–3
31. Kim VN (2005) MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol 6:376–385
32. Knoll B, Drescher U (2002) Ephrin-as as receptors in topographic projections. Trends Neurosci 25:145–149
33. Knoll B, Zarbalis K, Wurst W, Drescher U (2001) A role for the EphA family in the topographic targeting of vomeronasal axons. Development 128:895–906
34. Krol J, Loedige I, Filipowicz W (2010) The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 11:597–610
35. Liu K, Lu Y, Lee JK, et al. (2010) PTEN deletion enhances the regenerative ability of adult corticospinal neurons. Nat Neurosci 13:1075–1081
36. Marquardt T, Shirasaki R, Ghosh S, et al. (2005) Coexpressed EphA receptors and ephrin-a ligands mediate opposing actions on growth cone navigation from distinct membrane domains. Cell 121:127–139
37. Martinez A, Soriano E (2005) Functions of ephrin/Eph interactions in the development of the nervous system: emphasis on the hippocampal system. Brain Res Brain Res Rev 49:211–226
38. McLaughlin T, Hindges R, O’Leary DD (2003) Regulation of axial patterning of the retina and its topographic mapping in the brain. Curr Opin Neurobiol 13:57–69
39. Müller J, Ossig C, Greiner JF, et al. (2015) Intrastriatal transplantation of adult human neural crest-derived stem cells improves functional outcome in parkinsonian rats. Stem Cells Transl Med 4:31–43
40. Murai KK, Nguyen LN, Irie F, Yamaguchi Y, Pasquale EB (2003) Control of hippocampal dendritic spine morphology through ephrin-A3/EphA4 signaling. Nat Neurosci 6:153–160
41. Natera-Naranjo O, Aschrafi A, Gioio AE, Kaplan BB (2010) Identification and quantitative analyses of microRNAs located in the distal axons of sympathetic neurons. RNA 16:1516–1529
42. Pittman A, Chien CB (2002) Understanding dorsoventral topography: backwards and forwards. Neuron 35:409–411
43. Remy P (2014) Biotherapies for Parkinson disease. Rev Neurol (Paris) 170:763–769
44. Rhee YH, Ko JY, Chang MY, et al. (2011) Protein-based human iPS cells efficiently generate functional dopamine neurons and can treat a rat model of Parkinson disease. J Clin Invest 121:2326–2335
45. Schratt G (2009) microRNAs at the synapse. Nat Rev Neurosci 10:842–849
46. Seiradake E, Schaupp A, del Toro RD, et al. (2013) Structurally encoded intraclass differences in EphA clusters drive distinct cell responses. Nat Struct Mol Biol 20:958–964
47. Shin ES, Hwang O, Hwang YS, Suh JK, Chun YI, Jeon SR (2014) Enhanced efficacy of human brain-derived neural stem cells by transplantation of cell aggregates in a rat model of Parkinson’s disease. J Korean Neurosurg Soc 56:383–389
48. Stein E, Savaskan NE, Ninnemann O, Nitsch R, Zhou R, Skutella T (1999) A role for the Eph ligand ephrin-A3 in entorhino-hippocampal axon targeting. J Neurosci 19:8885–8893
49. Vanderhaeghen P, Lu Q, Prakash N, et al. (2000) A mapping label required for normal scale of body representation in the cortex. Nat Neurosci 3:358–365
50. Vo N, Klein ME, Varlamova O, et al. (2005) A cAMP-response element binding protein-induced microRNA regulates neuronal morphogenesis. Proc Natl Acad Sci U S A 102:16426–16431
51. Wahl S, Barth H, Ciossek T, Aktories K, Mueller BK (2000) Ephrin-A5 induces collapse of growth cones by activating rho and rho kinase. J Cell Biol 149:263–270
52. Wang HU, Anderson DJ (1997) Eph family transmembrane ligands can mediate repulsive guidance of trunk neural crest migration and motor axon outgrowth. Neuron 18:383–396
53. Wilkinson DG (2001) Multiple roles of EPH receptors and ephrins in neural development. Nat Rev Neurosci 2:155–164
54. Xu B, Li S, Brown A, Gerlai R, Fahnestock M, Racine RJ (2003) EphA/ephrin-a interactions regulate epileptogenesis and activity-dependent axonal sprouting in adult rats. Mol Cell Neurosci 24:984–999
55. Yu JY, Chung KH, Deo M, Thompson RC, Turner DL (2008) MicroRNA miR-124 regulates neurite outgrowth during neuronal differentiation. Exp Cell Res 314:2618–2633
56. Yue X, Dreyfus C, Kong TA, Zhou R (2008) A subset of signal transduction pathways is required for hippocampal growth cone collapse induced by ephrin-A5. Dev Neurobiol 68:1269–1286